- Home
- IMAB vs GCV Comparison
IMAB vs GCV Comparison
Compare IMAB & GCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- GCV
- Stock Information
- Founded
- IMAB 2014
- GCV 1988
- Country
- IMAB United States
- GCV United States
- Employees
- IMAB N/A
- GCV N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- GCV Finance/Investors Services
- Sector
- IMAB Health Care
- GCV Finance
- Exchange
- IMAB Nasdaq
- GCV Nasdaq
- Market Cap
- IMAB 83.8M
- GCV 72.1M
- IPO Year
- IMAB 2020
- GCV N/A
- Fundamental
- Price
- IMAB $1.39
- GCV $3.71
- Analyst Decision
- IMAB Strong Buy
- GCV
- Analyst Count
- IMAB 3
- GCV 0
- Target Price
- IMAB $8.00
- GCV N/A
- AVG Volume (30 Days)
- IMAB 378.4K
- GCV 57.9K
- Earning Date
- IMAB 08-28-2024
- GCV 01-01-0001
- Dividend Yield
- IMAB N/A
- GCV 13.04%
- EPS Growth
- IMAB N/A
- GCV N/A
- EPS
- IMAB N/A
- GCV N/A
- Revenue
- IMAB $3,492,091.00
- GCV N/A
- Revenue This Year
- IMAB N/A
- GCV N/A
- Revenue Next Year
- IMAB N/A
- GCV N/A
- P/E Ratio
- IMAB N/A
- GCV N/A
- Revenue Growth
- IMAB N/A
- GCV N/A
- 52 Week Low
- IMAB $0.99
- GCV $3.15
- 52 Week High
- IMAB $2.54
- GCV $4.58
- Technical
- Relative Strength Index (RSI)
- IMAB 63.28
- GCV 41.97
- Support Level
- IMAB $1.02
- GCV $3.58
- Resistance Level
- IMAB $1.50
- GCV $3.80
- Average True Range (ATR)
- IMAB 0.10
- GCV 0.13
- MACD
- IMAB 0.04
- GCV -0.02
- Stochastic Oscillator
- IMAB 77.08
- GCV 26.53
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.